This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Lumosa Therapeutics


Company Introduction

Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug development, the company is also actively engaged in scientific licensing and co-development collaboration, building a pipeline from early to late-stage assets consisting of first-in-class and best-in-class drug products through leveraging the company’s broad global network and drug development competence.

Our Mission

Enrich the quality of life through pioneering medical science, diverse collaborations, and the commitment to remain genuine and ever-evolving. Lumosa develops all aspects of talent in creative ways encouraging employees to exploit their strengths regardless of their positions to lead and inspire others.